CDH6
Cadherin-6
Also known as: CADH6_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P55285
- Gene
- CDH6
- Ensembl
- ENSG00000113361
- Chromosome
- 5
- Canonical length
- 790 aa
- Protein class
- Plasma proteins, Predicted membrane proteins
- Subcellular location
- Plasma membrane,Cell Junctions
OverviewNCBI Gene
This gene encodes a member of the cadherin superfamily. Cadherins are membrane glycoproteins that mediate homophilic cell-cell adhesion and play critical roles in cell differentiation and morphogenesis. The encoded protein is a type II cadherin and may play a role in kidney development as well as endometrium and placenta formation. Decreased expression of this gene may be associated with tumor growth and metastasis. [provided by RefSeq, May 2011]
Canonical amino-acid sequenceUniProt
790 residues, UniProt reviewed canonical sequence.
>P55285|CDH6
1 MRTYRYFLLL FWVGQPYPTL STPLSKRTSG FPAKKRALEL SGNSKNELNR SKRSWMWNQF
61 FLLEEYTGSD YQYVGKLHSD QDRGDGSLKY ILSGDGAGDL FIINENTGDI QATKRLDREE
121 KPVYILRAQA INRRTGRPVE PESEFIIKIH DINDNEPIFT KEVYTATVPE MSDVGTFVVQ
181 VTATDADDPT YGNSAKVVYS ILQGQPYFSV ESETGIIKTA LLNMDRENRE QYQVVIQAKD
241 MGGQMGGLSG TTTVNITLTD VNDNPPRFPQ STYQFKTPES SPPGTPIGRI KASDADVGEN
301 AEIEYSITDG EGLDMFDVIT DQETQEGIIT VKKLLDFEKK KVYTLKVEAS NPYVEPRFLY
361 LGPFKDSATV RIVVEDVDEP PVFSKLAYIL QIREDAQINT TIGSVTAQDP DAARNPVKYS
421 VDRHTDMDRI FNIDSGNGSI FTSKLLDRET LLWHNITVIA TEINNPKQSS RVPLYIKVLD
481 VNDNAPEFAE FYETFVCEKA KADQLIQTLH AVDKDDPYSG HQFSFSLAPE AASGSNFTIQ
541 DNKDNTAGIL TRKNGYNRHE MSTYLLPVVI SDNDYPVQSS TGTVTVRVCA CDHHGNMQSC
601 HAEALIHPTG LSTGALVAIL LCIVILLVTV VLFAALRRQR KKEPLIISKE DIRDNIVSYN
661 DEGGGEEDTQ AFDIGTLRNP EAIEDNKLRR DIVPEALFLP RRTPTARDNT DVRDFINQRL
721 KENDTDPTAP PYDSLATYAY EGTGSVADSL SSLESVTTDA DQDYDYLSDW GPRFKKLADM
781 YGGVDSDKDSLocalizationUniProt · AlphaFold · HPA
Whether an antibody against CDH6 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.4
- Highest tissue expression
- 14 nTPM
Expression across tissuesHPA
Tissue
- kidney: 14 nTPM
- blood vessel: 12 nTPM
- gallbladder: 8.7 nTPM
- fallopian tube: 6.4 nTPM
- cerebral cortex: 5.2 nTPM
- adipose tissue: 4.7 nTPM
Single-cell type
- proximal tubule cells: 419 nCPM
- vascular smooth muscle cells: 222 nCPM
- pericytes: 214 nCPM
- erythrocyte progenitors: 160 nCPM
- pituicytes/fscs: 113 nCPM
- megakaryocyte progenitors: 112 nCPM
Immune cell
- basophil: 0.1 nTPM
- neutrophil: 0.1 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
Brain region
- thalamus: 26 nTPM
- midbrain: 26 nTPM
- basal ganglia: 25 nTPM
- hypothalamus: 21 nTPM
- pons: 19 nTPM
- medulla oblongata: 16 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.34
- gnomAD pLI
- 0.92
- gnomAD missense Z
- 2.39
- DepMap mean gene effect
- 0.07
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- adherens junction organization
- calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules
- cell adhesion
- cell migration
- cell morphogenesis
- cell-cell adhesion mediated by cadherin
- cell-cell junction assembly
- homophilic cell adhesion via plasma membrane adhesion molecules
- Notch signaling pathway
- synaptic membrane adhesion
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads CDH6 as an antibody target. Whether an autoantibody or antibody against CDH6 could matter depends on whether native CDH6 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
CDH6 is annotated at the cell surface, where native CDH6 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label CDH6 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...